Topographical and biological evidence revealed FTY720-mediated anergy-polarization of mouse bone marrow-derived dendritic cells in vitro

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Zeng, Xiangfeng ^a   Wang, Tong ^a   Zhu, Cairong ^b   Xing, Xiaobo ^a,c   Ye, Yanxia ^a   Lai, Xinqiang ^a   Song, Bing ^a   Zeng, Yaoying ^a  

^a JINAN UNIVERSITY   (China)

^b GUANGZHOU WOMEN AND CHILDREN S MEDICAL CENTER   (China)

^c SOUTH CHINA NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FINGOLIMOD; CCR7 PROTEIN, MOUSE; CHEMOKINE RECEPTOR CCR7; CYTOKINE; DRUG DERIVATIVE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROPANEDIOL DERIVATIVE; SPHINGOSINE;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW CELL; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; DRUG ACTIVITY; DRUG STRUCTURE; ENDOCYTOSIS; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; IN VITRO STUDY; MORPHOLOGY; MOUSE; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; POLARIZATION; SCANNING ELECTRON MICROSCOPY; TOPOGRAPHY; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; FEMALE; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTIGEN PRESENTATION; BONE MARROW CELLS; CELL SURVIVAL; CYTOKINES; DENDRITIC CELLS; FEMALE; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; NITRIC OXIDE; PHAGOCYTOSIS; PHENOTYPE; PROPYLENE GLYCOLS; RECEPTORS, CCR7; SPHINGOSINE;

EID: 84861714055     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034830     Document Type: Article

References (61)

1. Ludewig B, Freigang S, Jaggi M, Kurrer MO, Pei YC, et al. (2000) Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model. Proc Natl Acad Sci U S A 97: 12752-12757.
2. Bobryshev YV, (2005) Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur Heart J 26: 1700-1704.
3. Sun J, Hartvigsen K, Chou MY, Zhang Y, Sukhova GK, et al. (2010) Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice. Circulation 122: 808-820.
4. Koltsova EK, Ley K, (2011) How dendritic cells shape atherosclerosis. Trends Immunol 32: 540-547.
5. Karp CL, Wysocka M, Ma X, Marovich M, Factor RE, et al. (1998) Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance. Eur J Immunol 28: 3128-3136.
6. Wysocka M, Robertson S, Riemann H, Caamano J, Hunter C, et al. (2001) IL-12 suppression during experimental endotoxin tolerance: dendritic cell loss and macrophage hyporesponsiveness. J Immunol 166: 7504-7513.
7. Blanco P, Palucka AK, Pascual V, Banchereau J, (2008) Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine & growth factor reviews 19: 41-52.
8. Eriksson U, Ricci R, Hunziker L, Kurrer MO, Oudit GY, et al. (2003) Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 9: 1484-1490.
9. Greter M, Heppner FL, Lemos MP, Odermatt BM, Goebels N, et al. (2005) Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med 11: 328-334.
10. Chen M, Wang YH, Wang Y, Huang L, Sandoval H, et al. (2006) Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311: 1160-1164.
11. Chino T, Draves KE, Clark EA, (2009) Regulation of dendritic cell survival and cytokine production by osteoprotegerin. J Leukoc Biol 86: 933-940.
12. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, et al. (2002) Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3: 673-680.
13. Banchereau J, Steinman RM, (1998) Dendritic cells and the control of immunity. Nature 392: 245-252.
14. Fujita T, Inoue K, Yamamoto S, Ikumoto T, Sasaki S, et al. (1994) Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite. J Antibiot (Tokyo) 47: 208-215.
15. Mehling M, Brinkmann V, Antel J, Bar-Or A, Goebels N, et al. (2008) FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis. Neurology 71: 1261-1267.
16. Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, et al. (2010) Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 362: 402-415.
17. Aktas O, Kury P, Kieseier B, Hartung HP, (2010) Fingolimod is a potential novel therapy for multiple sclerosis. Nat Rev Neurol 6: 373-382.
18. Brinkmann V, Billich A, Baumruker T, Heining P, Schmouder R, et al. (2010) Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov 9: 883-897.
19. Muller H, Hofer S, Kaneider N, Neuwirt H, Mosheimer B, et al. (2005) The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells. Eur J Immunol 35: 533-545.
20. Lan YY, De Creus A, Colvin BL, Abe M, Brinkmann V, et al. (2005) The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo. Am J Transplant 5: 2649-2659.
21. Green CE, Liu T, Montel V, Hsiao G, Lester RD, et al. (2009) Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis and neovascularization. PLoS One 4: e6713.
22. Xing F, Wang J, Hu M, Yu Y, Chen G, et al. (2011) Comparison of immature and mature bone marrow-derived dendritic cells by atomic force microscopy. Nanoscale research letters 6: 455.
23. Cai X, Xing X, Cai J, Chen Q, Wu S, et al. (2010) Connection between biomechanics and cytoskeleton structure of lymphocyte and Jurkat cells: An AFM study. Micron 41: 257-262.
24. Wang Q, Wang M, Li S, Xing X, Liu X, et al. (2011) AFM detection of mitogen-induced morphological changes in human B lymphocyte. Scanning.
25. Giordano D, Magaletti DM, Clark EA, (2006) Nitric oxide and cGMP protein kinase (cGK) regulate dendritic-cell migration toward the lymph-node-directing chemokine CCL19. Blood 107: 1537-1545.
26. Yanagihara S, Komura E, Nagafune J, Watarai H, Yamaguchi Y, (1998) EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J Immunol 161: 3096-3102.
27. Marsland BJ, Battig P, Bauer M, Ruedl C, Lassing U, et al. (2005) CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells. Immunity 22: 493-505.
28. Sanchez-Sanchez N, Riol-Blanco L, Rodriguez-Fernandez JL, (2006) The multiple personalities of the chemokine receptor CCR7 in dendritic cells. J Immunol 176: 5153-5159.
29. Bogdan C, (2001) Nitric oxide and the immune response. Nat Immunol 2: 907-916.
30. Sozzani S, Luini W, Borsatti A, Polentarutti N, Zhou D, et al. (1997) Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol 159: 1993-2000.
31. Adachi K, Chiba K, (2008) FTY720 story. Its discovery and the following accelerated development of sphingosine 1-phosphate receptor agonists as immunomodulators based on reverse pharmacology. Perspect Medicin Chem 1: 11-23.
32. Chen JK, Lane WS, Schreiber SL, (1999) The identification of myriocin-binding proteins. Chem Biol 6: 221-235.
33. Idzko M, Hammad H, van Nimwegen M, Kool M, Muller T, et al. (2006) Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. J Clin Invest 116: 2935-2944.
34. Heng Y, Ma Y, Yin H, Duan L, Xiong P, et al. (2010) Adoptive transfer of FTY720-treated immature BMDCs significantly prolonged cardiac allograft survival. Transpl Int 23: 1259-1270.
35. Lin Y, Chen Y, Zeng Y, Wang T, Zeng S, (2005) Lymphocyte phenotyping and NK cell activity analysis in pregnant NOD/SCID mice. J Reprod Immunol 68: 39-51.
36. Ye Y, Zhang Y, Lu X, Huang X, Zeng X, et al. (2011) The anti-inflammatory effect of the SOCC blocker SK&F 96365 on mouse lymphocytes after stimulation by Con A or PMA/ionomycin. Immunobiology 216: 1044-1053.
37. Ferlazzo G, Semino C, Melioli G, (2001) HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. Immunology letters 76: 37-41.
38. Glasser SW, Senft AP, Whitsett JA, Maxfield MD, Ross GF, et al. (2008) Macrophage dysfunction and susceptibility to pulmonary Pseudomonas aeruginosa infection in surfactant protein C-deficient mice. J Immunol 181: 621-628.
39. Wang T, Gong N, Liu J, Kadiu I, Kraft-Terry SD, et al. (2008) Proteomic modeling for HIV-1 infected microglia-astrocyte crosstalk. PLoS One 3: e2507.
40. Lee GY, Lim CT, (2007) Biomechanics approaches to studying human diseases. Trends in biotechnology 25: 111-118.
41. Alaniz RC, Deatherage BL, Lara JC, Cookson BT, (2007) Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J Immunol 179: 7692-7701.
42. Silverman JM, Clos J, Horakova E, Wang AY, Wiesgigl M, et al. (2010) Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells. J Immunol 185: 5011-5022.
43. Thery C, Ostrowski M, Segura E, (2009) Membrane vesicles as conveyors of immune responses. Nature reviews Immunology 9: 581-593.
44. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ, (1999) Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94: 3791-3799.
45. Verhasselt V, Buelens C, Willems F, De Groote D, Haeffner-Cavaillon N, et al. (1997) Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J Immunol 158: 2919-2925.
46. Harizi H, Juzan M, Pitard V, Moreau JF, Gualde N, (2002) Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J Immunol 168: 2255-2263.
47. Sallusto F, Palermo B, Lenig D, Miettinen M, Matikainen S, et al. (1999) Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 29: 1617-1625.
48. Persidsky Y, Zheng J, Miller D, Gendelman HE, (2000) Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. J Leukoc Biol 68: 413-422.
49. Kipnis J, Derecki NC, Yang C, Scrable H, (2008) Immunity and cognition: what do age-related dementia, HIV-dementia and 'chemo-brain' have in common? Trends Immunol 29: 455-463.
50. Kadiu I, Wang T, Schlautman JD, Dubrovsky L, Ciborowski P, et al. (2009) HIV-1 transforms the monocyte plasma membrane proteome. Cell Immunol 258: 44-58.
51. Wang T, Gong N, Liu J, Kadiu I, Kraft-Terry SD, et al. (2008) HIV-1-infected astrocytes and the microglial proteome. J Neuroimmune Pharm 3: 173-186.
52. Gorantla S, Liu J, Wang T, Holguin A, Sneller HM, et al. (2008) Modulation of innate immunity by copolymer-1 leads to neuroprotection in murine HIV-1 encephalitis. Glia 56: 223-232.
53. Chaudhuri A, Yang B, Gendelman HE, Persidsky Y, Kanmogne GD, (2008) STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood 111: 2062-2072.
54. de Vera ME, Shapiro RA, Nussler AK, Mudgett JS, Simmons RL, et al. (1996) Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci U S A 93: 1054-1059.
55. Deakin AM, Payne AN, Whittle BJ, Moncada S, (1995) The modulation of IL-6 and TNF-alpha release by nitric oxide following stimulation of J774 cells with LPS and IFN-gamma. Cytokine 7: 408-416.
56. Hussain SP, He P, Subleski J, Hofseth LJ, Trivers GE, et al. (2008) Nitric oxide is a key component in inflammation-accelerated tumorigenesis. Cancer Res 68: 7130-7136.
57. Paolucci C, Rovere P, De Nadai C, Manfredi AA, Clementi E, (2000) Nitric oxide inhibits the tumor necrosis factor alpha-regulated endocytosis of human dendritic cells in a cyclic GMP-dependent way. J Biol Chem 275: 19638-19644.
58. Yanagawa Y, Onoe K, (2002) CCL19 induces rapid dendritic extension of murine dendritic cells. Blood 100: 1948-1956.
59. Kobayashi M, Azuma E, Ido M, Hirayama M, Jiang Q, et al. (2001) A pivotal role of Rho GTPase in the regulation of morphology and function of dendritic cells. J Immunol 167: 3585-3591.
60. Marsolais D, Yagi S, Kago T, Leaf N, Rosen H, (2011) Modulation of chemokines and allergic airway inflammation by selective local sphingosine-1-phosphate receptor 1 agonism in lungs. Mol Pharmacol 79: 61-68.
61. Mehling M, Hilbert P, Fritz S, Durovic B, Eichin D, et al. (2011) Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patients. Ann Neurol 69: 408-413.